Live Feeds
● LIVE Updated 1h ago · 10 sources tracked

GLP-1 injections recalled nationwide. See affected products

Federal health officials have issued a nationwide recall affecting multiple vials of compounded GLP-1 injections due to potential sterility issues. The Food and Drug Administration announced the action on compounded tirzepatide products manufactured by Apothecary Pharma. Patients across the United States who use these specific compounded injections are advised to check affected product details, including specific lot numbers, to determine if their medication is subject to the safety recall. The federal health agency previously initiated the action in September before updating the recall to a higher risk level.

🎙️

Listen to Live Briefing

Real-time synthesized voice briefing · Live Feeds Desk

⏱ ~3 min
Speed:
RSS Source map (10)
⚡ Key Developments & Real-Time Context
Text size:
  • ✓ Federal health officials recalled certain vials of compounded GLP-1 injections because the products may not be sterile.
  • ✓ A nationwide recall affects 22 Apothecary Pharma compounded tirzepatide vials.
  • ✓ The Food and Drug Administration updated the recall, which was initiated in September, to a higher risk level.
🛡️ Source Corroboration: 10 independent reporting domains (100% confidence) ⏱ Read time: ~2 min

What changed

The Food and Drug Administration updated the nationwide recall of compounded GLP-1 medications to a higher risk level.

Live updates

  1. Nationwide GLP-1 Recall Issued Over Sterility Issues

    Federal health officials have issued a nationwide recall affecting multiple vials of compounded GLP-1 injections due to potential sterility issues. The Food and Drug Administration announced the action on compounded tirzepatide products manufactured by Apothecary Pharma. Patients across the United States who use these specific compounded injections are advised to check affected product details, including specific lot numbers, to determine if their medication is subject to the safety recall. The federal health agency previously initiated the action in September before updating the recall to a higher risk level.

    Why it matters

    Compounded medications are created by pharmacies to meet individual patient needs when commercial drugs are unavailable, but they do not undergo the same FDA approval process as manufactured drugs. Safety concerns regarding sterility can pose significant health risks for injectable treatments. A Houston pharmacy behind the recalled compounded tirzepatide vials previously drew 14 FDA inspection observations.

    What is confirmed

    • Federal health officials recalled certain vials of compounded GLP-1 injections because the products may not be sterile.
    • A nationwide recall affects 22 Apothecary Pharma compounded tirzepatide vials.
    • The Food and Drug Administration updated the recall, which was initiated in September, to a higher risk level.

    Still unconfirmed

    • The Houston pharmacy behind the recalled vials drew 14 FDA inspection observations, including exposed skin and research-grade ingredients.

    What to watch next

    • Additional updates from the Food and Drug Administration regarding affected lot numbers
    • Further manufacturer announcements from Apothecary Pharma
    Sources used for this update (11)
    1. nypost.com — New York Post – Breaking News, Top Headlines, Photos & Videos
    2. help.naver.com — Futures Flat As Oil Rebounds After Trump's "Energy Ceasefire" Unravels, Memory Stocks Slide | ZeroHedge
    3. USA Today — GLP-1 injections recalled nationwide. See affected products
    4. Medical Daily — Houston Pharmacy Behind Recalled Compounded Tirzepatide Vials Drew 14 FDA Inspection Observations, Including Exposed Skin and Research-Grade Ingredients
    5. SuaraGarut.ID — FDA Recalls 22 Apothecary Pharma Tirzepatide Vials Nationwide
    6. MedShadow Foundation — FDA Recalls and Warnings: Sterility Issues With Compounded GLP-1s, Foreign Pills in Generic Reglan Bottles
    7. cashwalklabs.io — GLP-1 injections recalled nationwide. See affected products | Global Cashwalk
    8. www.wftv.com — Recall alert: Some GLP-1 injections recalled over sterility concerns
    9. www.drugwatch.com — Compounded GLP-1 Injections Recalled Over Sterility Issues
    10. www.yahoo.com — GLP-1 injections recalled nationwide: See affected lots and ...
    11. www.yahoo.com — FDA Announces Nationwide Recall of GLP-1 Medications ... - Yahoo
    confidence 100%
📊

Community Sentiment: How do you assess this situation?

Voice your perspective · Real-time aggregated sentiment from the Live Feeds community